The Impact of Docosahexaenoic Acid on Alzheimer’s Disease: Is There a Role of the Blood-Brain Barrier?

E-ISSN： 2212-3938|10|3|222-241

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.10, Iss.3, 2015-01, pp. : 222-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier A#946; Clearance in Alzheimers Disease

Current Pharmaceutical Design, Vol. 14, Iss. 16, 2008-06 ,pp. : 1601-1605

Bentham Science Publishers

Access to resources Recommend Favorite

A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer’s Disease Treatment

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 14, 2018-04 ,pp. : 1124-1131

Bentham Science Publishers

Access to resources Recommend Favorite

A novel, dynamic in vitro model of the blood-brain barrier (BBB) to predict central nervous system (CNS) accumulation of novel therapeutics (stroke, Alzheimer’s, epilepsy)

By Janigro D.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 257-260

Informa Healthcare

Access to resources Recommend Favorite

Clearance of Amyloid-#946; Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 1, 2009-03 ,pp. : 16-30

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating amyloid- peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions

By Mackic J.B. Bading J. Ghiso J. Walker L. Wisniewski T. Frangione B. Zlokovic B.V.

General Pharmacology, Vol. 38, Iss. 6, 2002-06 ,pp. : 303-313

Elsevier

Access to resources Recommend Favorite